In her 63rd try, Alize Cornet makes Grand Slam quarterfinals
By Associated Press
MELBOURNE: Alize Cornet has finally reached the quarterfinals of a Grand Slam tournament in her 63rd attempt.
The 32-year-old Cornet survived a…
Browsing Tag
63rd
Australian Open: Cornet upsets Halep in brutal heat to make Slam quarter on 63rd…
MELBOURNE: Unseeded French veteran Alize Cornet upset Simona Halep at the Australian Open in brutal heat Monday to make her first Grand Slam quarter-final on her 63rd attempt. Both players…
63rd All Indian Railways Men’s Basketball Championship from January 1 in…
Express News Service
NEW DELHI: The week-long 63rd All India Railway Men’s Basketball Championship commenced on a colourful note at Maligaon in Guwahati on Saturday,…
Corrected: Keros Therapeutics Presents Clinical Trial and Preclinical Study Results…
Lexington, Mass. – December 13, 2021 – Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS) is re-issuing this press release solely to correct inadvertent typographical errors under the…
Agios Presents Mitapivat Long-term Extension Data Demonstrating Durability of…
– Additional Data Presented at ASH Support the Potential of Mitapivat to Improve Ineffective Erythropoiesis and Iron Overload and Stabilize Bone Mineral Density in PK Deficiency Patients –…
Adaptive Biotechnologies Announces New Data Demonstrating the Benefit of Serial MRD…
Analysis of the MASTER trial (Abstract 481) showed clonoSEQ’s ability to measure deep and durable responses and permit treatment discontinuation in multiple myeloma patientsData in more…
Keros Therapeutics Presents Clinical Trial and Preclinical Study Results from its…
Keros Therapeutics will be hosting a conference call and webcast today, December 13, 2021, at 4:01 p.m. ET. LEXINGTON, Mass., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc.…
Allogene Therapeutics Reports Positive Results from Phase 1 UNIVERSAL Study of Single…
ALLO-715 UNIVERSAL Trial is the First Allogeneic anti-BCMA CAR T to Demonstrate Safety and Substantial Efficacy in Multiple Myeloma Updated Data Demonstrate Responses Similar to Approved…
Affimed Shares Preclinical Data on Innate Cell Engagers AFM28 and AFM13 at the 63rd…
AFM28 effectively induces depletion of leukemic cells in patient bone marrow samples and demonstrates the anticipated good safety profile and pharmacologic activity in cynomolgus…
TScan Therapeutics Announces Poster Presentations at the 63rd American Society of…
- Posters highlight discovery of TSC-101, manufacturing process and clinical development plan for liquid tumor candidates TSC-101 and TSC-102 - - Phase 1 clinical trial expected to…